Literature DB >> 25001459

Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.

Tzu-Lung Lin1, Pei-Fang Hsieh1, Yu-Tsung Huang2, Wei-Ching Lee1, Yi-Ting Tsai1, Po-An Su1, Yi-Jiun Pan1, Chun-Ru Hsu1, Meng-Chuan Wu1, Jin-Town Wang3.   

Abstract

BACKGROUND: Klebsiella pneumoniae causing community-acquired pyogenic liver abscess complicated with metastatic meningitis and endophthalmitis has emerged recently, most frequently associated with the K1 capsular type.
METHODS: A bacteriophage (NTUH-K2044-K1-1) that infects K. pneumoniae NTUH-K2044 (capsular type K1) was isolated and characterized.
RESULTS: The phage infected all K1 strains, and none of the strains with other capsular types. Capsule deletion mutants were not lysed by this phage, suggesting that the capsule was essential for phage infection. Complete genome sequencing revealed the phage was a novel phiKMV-like virus. The gene-encoding capsule depolymerase was identified. The recombinant enzyme demonstrated specific lysis of the K1 capsule. Treatment with the phage or the recombinant enzyme provided significantly increased survival in mice infected with NTUH-K2044 strain, including one treated after the detection of a neck abscess by imaging. No obvious disease was observed after administration of this phage in mice. Phage was retained at detectable levels in liver, spleen, brain, and blood 24 hours after administration in mice.
CONCLUSIONS: These results demonstrate this phage and its capsule depolymerase exhibit specificity for capsular type K1 and can be used for the diagnosis and treatment of K1 K. pneumoniae infections.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Klebsiella pneumoniae; capsule; capsule depolymerase; phage

Mesh:

Substances:

Year:  2014        PMID: 25001459     DOI: 10.1093/infdis/jiu332

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  61 in total

1.  A Tailspike with Exopolysaccharide Depolymerase Activity from a New Providencia stuartii Phage Makes Multidrug-Resistant Bacteria Susceptible to Serum-Mediated Killing.

Authors:  Hugo Oliveira; Graça Pinto; Bruna Mendes; Oscar Dias; Hanne Hendrix; Ergun Akturk; Jean-Paul Noben; Jan Gawor; Małgorzata Łobocka; Rob Lavigne; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

2.  K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.

Authors:  Hugo Oliveira; Ana Mendes; Alexandra G Fraga; Alice Ferreira; Andreia I Pimenta; Dalila Mil-Homens; Arsénio M Fialho; Jorge Pedrosa; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2019-08-14       Impact factor: 4.792

Review 3.  Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Candace M Marr
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

4.  Klebsiella Phage ΦK64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types.

Authors:  Yi-Jiun Pan; Tzu-Lung Lin; Ching-Ching Chen; Yun-Ting Tsai; Yi-Hsiang Cheng; Yi-Yin Chen; Pei-Fang Hsieh; Yi-Tsung Lin; Jin-Town Wang
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

5.  Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection.

Authors:  David Negus; Julia Vipond; Graham J Hatch; Emma L Rayner; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

6.  Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors:  A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

7.  Functional Analysis and Antivirulence Properties of a New Depolymerase from a Myovirus That Infects Acinetobacter baumannii Capsule K45.

Authors:  Hugo Oliveira; Ana Rita Costa; Alice Ferreira; Nico Konstantinides; Sílvio B Santos; Maarten Boon; Jean-Paul Noben; Rob Lavigne; Joana Azeredo
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

8.  Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment.

Authors:  Yi-Jiun Pan; Tzu-Lung Lin; Yi-Tsung Lin; Po-An Su; Chun-Tang Chen; Pei-Fang Hsieh; Chun-Ru Hsu; Ching-Ching Chen; Yu-Chia Hsieh; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

Review 9.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

10.  Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect.

Authors:  Min Li; Pei Li; Long Chen; Genglin Guo; Yuyi Xiao; Liang Chen; Hong Du; Wei Zhang
Journal:  Virus Genes       Date:  2021-06-22       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.